Novo Nordisk’s oral Wegovy pill for chronic weight loss is under FDA review. If approved, it would be the first oral GLP-1 ...

Hims & Hers Health Inc. (NYSE:HIMS) partners with Novo Nordisk to offer affordable weight-loss drug, positioning itself to ...

A federal court in Texas reportedly dismissed a bid by drug compounders to continue producing off-brand versions of Novo Nordisk‘s weight-loss drug Wegovy and diabetes treatment Ozempic while a ...

Novo Nordisk is racing to capture more patients now that many compounding pharmacies are restricted from making Wegovy ...

A bundled offering of Novo Nordisk’s FDA-approved ... offer access to other medications, oral kits, protein, nutrition kits, and clinically-backed care plans, giving patients more ways to ...

Hims & Hers said it will begin offering all dose sizes of Wegovy along with access to 24/7 care, nutritional ... the active ingredient in Novo Nordisk's diabetes drug Ozempic and Wegovy, in ...